SCHEMBL5066759

SCHEMBL5066759

COc1cc2c(cc1OC)C1CC(O)CCC1N=C2c1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 2/20 0.62
ALDH1A1 P00352 4/20 0.44
MAPT P10636 4/20 0.44
LMNA P02545 3/20 0.44
GHSR Q92847 1/20 0.42
KDM4E B2RXH2 3/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NOD2 Q9HC29 1/20 0.39
NPY5R Q15761 1/20 0.38
KIT P10721 1/20 0.38
NR2F2 P24468 1/20 0.37
CNR1 P21554 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064542 0.95 PDE4D (0.57) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL5058868 0.92 PDE4D (0.72) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL5063148 0.89 PDE4D (0.65) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL5064551 0.89 PDE4D (0.65) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL6390493 0.87 PDE4D (0.43) PDE4DALDH1A1LMNAKMT2APDE4A
SCHEMBL7356403 0.84 PDE4D (0.86) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL7356412 0.84 PDE4D (0.86) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL5063387 0.83 PDE4D (0.49) PDE4DALDH1A1MAPTPDE4APDE4B
SCHEMBL5058936 0.82 PDE4D (0.58) PDE4DALDH1A1MAPTLMNAGHSR
SCHEMBL6385822 0.80 PDE4D (0.47) PDE4DALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-07-03 US claimed
EP-1725533-A1 NOVEL THIO CONTAINING HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS Altana Pharma AG (DE) 2006-11-29 EP disclosed
WO-2005087744-A1 NOVEL THIO-CONTAINING HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS ALTANA PHARMA AG (DE) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE4C PDE4D 4/4885ALDH1A1 340/4885MAPT 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.